Genetic testing of athletes

Medicine and Sport Science

Volumn 54, Issue , 2009, Pages 176-186

  Williams, Alun G ^a   Wackerhage, Henning ^b  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATHLETIC PERFORMANCE; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; HUMAN; PHENOTYPE; RISK ASSESSMENT; SPORT; SPORT INJURY;

ATHLETIC INJURIES; ATHLETIC PERFORMANCE; GENETIC TESTING; GENETIC VARIATION; HUMANS; PHENOTYPE; RISK ASSESSMENT; SPORTS;

EID: 72049131810     PISSN: 02545020     EISSN: 16622812     Source Type: Book Series    
DOI: 10.1159/000235704     Document Type: Article

References (34)

1. Genetic Technologies Limited: Human DNA Testing: Sports Performance. Genetic Technologies Limited, 2008. http://www.gtg.com.au/HumanDNA Testing/index.asp?menuid = 070.110; retrieved 11 December 2008.
2. National Human Genome Research Institute: Genetic Information Nondiscrimination Act: 2007- 2008. National Human Genome Research Institute, 2008. http://www.genome.gov/24519851; retrieved January 2009.
3. Green MJ, Botkin JR: 'Genetic exceptionalism' in medicine: clarifying the differences between genetic and nongenetic tests. Ann Intern Med 2003;138:571-575.
4. Williams AG, Wackerhage H, Miah A, Harris RC, Montgomery HE: Genetic research and testing in sport and exercise science: BASES Position Stand. Leeds, British Association of Sport and Exercise Sciences, 2007.
5. Ruiz JR, Sui X, Lobelo F, Morrow JR Jr, Jackson AW, Sjostrom M, Blair SN: Association between muscular strength and mortality in men: prospective cohort study. BMJ 2008;337:a439.
6. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: high-avidity binding to betaamyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
7. Human Genetics Commission: Genetic information, public consultation: Second Annual Report of the Human Genetics Commission. London, Human Genetics Commission, 2002.
8. Bray MS, Hagberg JM, Perusse L, Rankinen T, Roth SM, Wolfarth B, Bouchard C: The human gene map for performance and health-related fitness phenotypes: the 2006-2007 update. Med Sci Sports Exerc 2009;41:35-73.
9. Juvonen E, Ikkala E, Fyhrquist F, Ruutu T: Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin. Blood 1991;78:3066-3069.
10. de la Chapelle A, Traskelin AL, Juvonen E: Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci USA 1993;90:4495-4499.
11. Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee S-J: Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004;350:2682-2688.
12. McPherron AC, Lawler AM, Lee SJ: Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997;387:83-90.
13. Mendias CL, Bakhurin KI, Faulkner JA: Tendons of myostatin-deficient mice are small, brittle, and hypocellular. Proc Natl Acad Sci USA 2008;105:388-393.
14. Myerson S, Hemingway H, Budget R, Martin J, Humphries S, Montgomery H: Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol 1999;87:1313-1316.
15. Williams AG, Rayson MP, Jubb M, World M, Woods DR, Hayward M, Martin J, Humphries SE, Montgomery HE: The ACE gene and muscle performance. Nature 2000;403:614.
16. Zhang B, Tanaka H, Shono N, Miura S, Kiyonaga A, Shindo M, Saku K: The I allele of the angiotensinconverting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin Genet 2003;63:139-144.
17. Rankinen T, Perusse L, Gagnon J, Chagnon YC, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C: Angiotensin-converting enzyme ID polymorphism and fitness phenotype in the HERITAGE Family Study. J Appl Physiol 2000;88:1029-1035.
18. Yang N, MacArthur DG, Gulbin JP, Hahn AG, Beggs AH, Easteal S, North K: ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 2003;73:627-631.
19. Niemi AK, Majamaa K: Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. Eur J Hum Genet 2005;13:965-969.
20. MacArthur DG, Seto JT, Chan S, Quinlan KG, Raftery JM, Turner N, Nicholson MD, Kee AJ, Hardeman EC, Gunning PW, Cooney GJ, Head SI, Yang N, North KN: An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance. Hum Mol Genet 2008;17:1076-1086.
21. Clarkson PM, Devaney JM, Gordish-Dressman H, Thompson PD, Hubal MJ, Urso M, Price TB, Angelopoulos TJ, Gordon PM, Moyna NM, Pescatello LS, Visich PS, Zoeller RF, Seip RL, Hoffman EP: ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J Appl Physiol 2005;99:154-163.
22. Moran CN, Yang N, Bailey ME, Tsiokanos A, Jamurtas A, Macarthur DG, North K, Pitsiladis YP, Wilson RH: Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks. Eur J Hum Genet 2007;15:88-93.
23. Conley DL, Krahenbuhl GS: Running economy and distance running performance of highly trained athletes. Med Sci Sports Exerc 1980;12:357-360.
24. Lucia A, Olivan J, Gomez-Gallego F, Santiago C, Montil M, Foster C: Citius and longius (faster and longer) with no alpha-actinin-3 in skeletal muscles? Br J Sports Med, 2007. http://bjsm.bmj.com/cgi/ content/abstract/41/9/ 616; retrieved 12 December 2008.
25. Mokone GG, Gajjar M, September AV, Schwellnus MP, Greenberg J, Noakes TD, Collins M: The guanine- thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with Achilles tendon injuries. Am J Sports Med 2005;33: 1016-1021.
26. Williams AG, Folland JP: Similarity of polygenic profiles limits the potential for elite human physical performance. J Physiol 2008;586:113-121.
27. Roth SM: Perspective on the future use of genomics in exercise prescription. J Appl Physiol 2008;104: 1243-1245.
28. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G: Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593-1601. (Pubitemid 44515020)
29. Hogarth S, Javitt G, Melzer D: The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues. Annu Rev Genomics Hum Genet 2008;9:161-182.
30. Rantanen E, Hietala M, Kristoffersson U, Nippert I, Schmidtke J, Sequeiros J, Kaariainen H: What is ideal genetic counselling? A survey of current international guidelines. Eur J Hum Genet 2008;16:445-452.
31. Osterweil N: Full court press on hoop star Curry to get DNA testing. MedPage Today, 2005. http://www. medpagetoday.com/Cardiology/Arrhythmias/1843; retrieved 7 January 2009.
32. World Anti-Doping Agency: WADA gene doping symposium reaches conclusions and recommendations. World Anti-Doping Agency, 2005. http:// www.wada-ama.org/en/newsarticle.ch2?articleId = 3115229; retrieved 7 January 2009.
33. Nicolas P: Ethical and juridical issues of genetic testing: a review of the international regulation. Crit Rev Oncol Hematol 2009;69:98-107.
34. Hesketh T, Xing ZW: Abnormal sex ratios in human populations: causes and consequences. Proc Natl Acad Sci USA 2006;103:13271-13275.